CAMBRIDGE, Mass.--(BUSINESS WIRE)--PixarBio Corporation inventors of NeuroRelease, a 14-day non-opioid, non-addictive, post-surgical pain treatment with expected FDA approval in 2018, today announced that it has been named one of the “Best Places to Work” by the Boston Business Journal.
PixarBio has been selected as a best place to work, extra small category (20-49 employees), on the annual regional list created by the Boston Business Journal, a cross-industry publication in the Boston area. The Boston Business Journal surveys local companies to determine which firms offer the greatest professional opportunities and work environments.
